June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
Utility and Uncorrected Refractive Error
Author Affiliations & Notes
  • Nina Tahhan
    Brien Holden Vision Institute, Sydney, NSW, Australia
    School of Optometry & Vision Science, UNSW, Sydney, NSW, Australia
  • Eric Papas
    Brien Holden Vision Institute, Sydney, NSW, Australia
    Vision Cooperative Research Centre, Sydney, NSW, Australia
  • Timothy Fricke
    Brien Holden Vision Institute, Sydney, NSW, Australia
  • Kevin Frick
    Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
  • Brien Holden
    Brien Holden Vision Institute, Sydney, NSW, Australia
    Vision Cooperative Research Centre, Sydney, NSW, Australia
  • Footnotes
    Commercial Relationships Nina Tahhan, None; Eric Papas, None; Timothy Fricke, None; Kevin Frick, Center for Applied Value Analysis (C), National Association for Eye and Vision Research (C); Brien Holden, Allergan (F), AMO (I)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5330. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Nina Tahhan, Eric Papas, Timothy Fricke, Kevin Frick, Brien Holden; Utility and Uncorrected Refractive Error. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5330.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Utilities are preference based quality of life (QoL) measures used in health economic evaluations such as cost-effectiveness studies. Utilities have been derived for a variety of ocular conditions but not previously reported for uncorrected refractive error (URE). This study evaluates utility associated with URE.

Methods: This was a cross-sectional study involving participants presenting for an eye exam at a university based clinic. Participants met study criteria if aged 40-65 years, wore refractive error correction and had no ocular disease impairing vision worse than 0.1 LogMAR units in the better eye. All participants underwent a comprehensive eye examination including refraction, aided and unaided VA measures at 6m and 40cm using a Bailey-Lovie LogMAR chart. Utilities were elicited using the Time Trade-Off (TTO) method for a number of scenarios including the participants own corrected and uncorrected vision state. Utilities ranged from 0-1 where 0=death and 1=perfect vision and were scaled to account for co-morbidities so that 1= perfect health (adjusted utility).

Results: Data analysis was based on a cohort of 341 participants (out of 361 screened). Unaided, 30 participants had no vision impairment, 65 had only distance vision impairment (DVI), 97 had only near vision impairment (NVI), 112 had moderate amounts of both distance and near vision impairment (DNVI) and 37 had severe impairment (distance or near impairment >1.0 LogMAR units) in the better eye. Unaided VA was DVI group 0.50±0.24 LogMAR at distance, NVI group 0.43±0.17 LogMAR at near, and DNI group 0.72±0.36 at distance and 0.56±0.29 at near. Adjusted utilities for the three groups were DVI 0.82±0.16, NVI 0.81±0.17 and DNVI 0.68±0.25. The (adjusted and unadjusted) DVI and NVI utilities did not significantly differ (p=0.73 and p=0.77 respectively). DNVI utility was significantly worse than DVI and NVI (adjusted and unadjusted p<0.01).

Conclusions: URE is associated with measurable reductions in utility (and therefore QoL). Reductions are similar irrespective of whether near or distance vision is impaired but worse when both are impaired. The results underscore the significance of URE on QoL, particularly with respect to uncorrected presbyopia which has been a relatively neglected area in research and policy. The utility figures in this study can be used as inputs for cost-effectiveness evaluations for programs relating to URE to assist governments with resource allocation decisions.

Keywords: 460 clinical (human) or epidemiologic studies: health care delivery/economics/manpower • 669 quality of life • 754 visual acuity  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.